Optimisation Strategy for Emergency Tracheal Intubation
Launched by UNIVERSITY HOSPITAL, BORDEAUX · Sep 13, 2022
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to help patients who need emergency tracheal intubation, which is a procedure used to open the airway in critical situations. The researchers want to see if using a combination of techniques—such as a muscle relaxant called rocuronium, using a bag mask to help with breathing before the intubation, and a special tool called a Gum Elastic Bougie—can reduce complications related to the intubation process. The goal is to improve the safety and effectiveness of this life-saving procedure for patients in distress.
To participate in this trial, patients must be at least 18 years old and experiencing severe health issues that require emergency intubation, such as difficulty breathing, trauma, or altered consciousness. However, patients who are in cardiac arrest or have certain medical conditions that prevent them from using the muscle relaxant or bag mask will not be eligible. If you or someone you know qualifies, you can expect to receive care from experienced medical professionals who will follow this new strategy to ensure the best possible outcomes during this critical procedure.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient adult (≥ 18 years) presenting with vital distress requiring emergency tracheal intubation as assessed by the emergency physician in the out-of-hospital setting.
- • Patient with all conditions (trauma, dyspnea, coma, overdoses, and shock) except those in cardiac arrest will be included.
- Exclusion Criteria:
- • Patient presenting of a contraindication to succinylcholine, and/or rocuronium, and/or sugammadex (rocunorium antagonist).
- • Patient who have contraindication to bag face mask ventilation before intubation (ongoing emesis, hematemesis, or hemoptysis).
- • Patient that are not members of a medical aid scheme (beneficiary or main member).
- • Patient under specific protection measures: pregnant, parturient or nursing women; legal protection or deprived of liberty: patient under judicial protection, patient under guardianship/curatorship.
About University Hospital, Bordeaux
The University Hospital of Bordeaux is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution integrates cutting-edge scientific inquiry with patient care, fostering an environment that encourages collaboration among multidisciplinary teams. With a commitment to improving treatment outcomes and enhancing patient safety, the University Hospital of Bordeaux plays a pivotal role in the development of new therapies and medical technologies, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Angers, , France
Bordeaux, , France
Poitiers, , France
Bordeaux, , France
Toulouse, , France
Lyon, , France
Melun, , France
Garches, , France
Beaumont Sur Oise, , France
Bobigny, , France
Cergy Pontoise, , France
Créteil, , France
Eaubonne, , France
La Tronche, , France
Montpellier, , France
Nantes, , France
Paris, , France
Paris, , France
Paris, , France
Saint Denis, , France
Saint Pierre, , France
Patients applied
Trial Officials
Xavier COMBES, Pr
Principal Investigator
Université Hospital, Bordeaux
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials